Skip to main content
BDTX
NASDAQ Life Sciences

Silevertinib Shows 86% CNS Response Rate in Untreated Brain Metastases

Tom Rudovsky · Reported by Dow Jones Newswires
More coverage: Biotech Stocks · Healthcare
Sentiment info
Positive
Importance info
8
Price
$2
Mkt Cap
$106.864M
52W Low
$1.6
52W High
$4.94
52W Position info
25% above low
Off High info
60% below high
Rel. Volume info
1.1× avg
Market data snapshot near publication time

BDTX sits 25% above its 52-week low of $1.6.

Summary

Black Diamond reported updated Phase 2 silevertinib data showing an 86% CNS objective response rate in patients with untreated brain metastases and a 15.0-month median progression-free survival. That is a strong efficacy readout for a micro-cap oncology name whose entire thesis rests on this program. The company had already scheduled a webcast for 7:30 a.m. ET today to present the data, and the 8-K with the same figures hit this morning. FDA feedback supports a clear path to potential registration in 1L EGFR-NCM NSCLC. Cash is the other half of the story: the last 10-Q cut runway guidance to Q2 2027 from H2 2028, so a positive data set raises the odds of a financing or partnership rather than removing the funding question.

At the time of this announcement, BDTX was trading at $2.00 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $106.9M. The 52-week trading range was $1.60 to $4.94. This news item was assessed with positive market sentiment and an importance score of 8 out of 10. Source: Dow Jones Newswires.


Price Chart

Share this article

Copied!

BDTX - Latest Insights

BDTX
Nov 10, 2026, 6:31 AM EST
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $2.00
Real-time Price: $1.97 info
Change: -$0.0296 (-1%) info
Market Cap: $106.864M info
BDTX
Nov 10, 2026, 6:28 AM EST
Filing Type: 8-K
Importance Score:
8
Price at Filing: $2.02
Real-time Price: $1.97 info
Change: -$0.0496 (-2%) info
Market Cap: $106.864M info
BDTX
Nov 09, 2026, 4:01 PM EST
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $1.95
Real-time Price: $1.97 info
Change: +$0.0204 (+1%) info
Market Cap: $106.864M info
BDTX
May 21, 2026, 5:19 PM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $3.19
Real-time Price: $1.97 info
Change: -$1.22 (-38%) info
Market Cap: $106.864M info
BDTX
May 21, 2026, 5:13 PM EDT
Source: GlobeNewswire
Importance Score:
9
Price at Filing: $3.27
Real-time Price: $1.97 info
Change: -$1.30 (-40%) info
Market Cap: $106.864M info